Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed) ...
SomnoMed Limited (ASX: SOM), the global leader in oral appliance therapy for obstructive sleep apnea (OSA), today announced a significant investment in its managed care infrastructure to continue ...
Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Anti-Snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, Above ...
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...
SomnoMed (ASX:SOM) shares have surged after breaking sales records for its sleep apnea products in the North America, Europe and APAC/Japan regions during the 2013/14 financial year. It also expects ...
Hosted on MSN
SomnoMed announces director’s interest change
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
The SomnoMed Limited (ASX: SOM) share price has closed at a 52-week-high after making a spectacular recovery over the last 12 months. You’re reading a free article with opinions that may differ from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback